Patients with wet macular degeneration (MD) who are receiving Avastin injections will again be entitled to a Medicare Rebate.
Read MoreFoundation’s campaigns leading to increase in macular degeneration awareness in Australia.
Read MoreAn advocacy campaign relating to the Extended Medicare Safety Net has been resolved positively for thousands of elderly Australians with wet AMD.
Read MoreNew changes to Medicare mean a $200 rebate is no longer available for the administration of Avastin as a treatment for MD.
Read MoreThe Vision Van – a mobile eye screening van to increase detection of AMD – has been launched.
Read MoreNew research reveals Aussies are at risk of going blind but don’t know it.
Read MoreMacular Degeneration Foundation welcomed the decision to list the sight-saving treatment, Lucentis; on the Pharmaceutical Benefits Scheme (PBS).
Read MoreMacular Degeneration Foundation calls on the Federal Government to speed the accessibility and affordability of Lucentis.
Read More